Hims & Hers Health, Inc.
General ticker "HIMS" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $9.8B (TTM average)
Hims & Hers Health, Inc. follows the US Stock Market performance with the rate: 25.9%.
Estimated limits based on current volatility of 2.8%: low 30.25$, high 31.98$
Factors to consider:
- Total employees count: 1637 (+56.5%) as of 2024
- Top business risk factors: Rapid growth and scalability challenges, Market competition, Reputation and brand risks, Regulatory and compliance, Security breaches
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [21.76$, 40.84$]
- 2025-12-31 to 2026-12-31 estimated range: [20.36$, 38.48$]
Financial Metrics affecting the HIMS estimates:
- Positive: with PPE of 95.7 at the end of fiscal year the price was neutral
- Positive: -5.02 < Operating profit margin, % of 4.19
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 0.04 < Operating cash flow per share per price, % of 4.34
- Positive: Investing cash flow per share per price, % of -0.33 > -0.62
- Positive: Return on assets ratio (scaled to [-100,100]) of 15.12 > 6.04
- Negative: Shareholder equity ratio, % of 67.38 > 64.17
Short-term HIMS quotes
Long-term HIMS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $526.92MM | $872.00MM | $1,476.51MM |
| Operating Expenses | $595.61MM | $901.45MM | $1,414.61MM |
| Operating Income | $-68.70MM | $-29.45MM | $61.90MM |
| Non-Operating Income | $2.99MM | $7.88MM | $9.81MM |
| R&D Expense | $29.24MM | $48.23MM | $78.82MM |
| Income(Loss) | $-65.71MM | $-21.57MM | $71.71MM |
| Taxes | $-0.03MM | $1.98MM | $-54.33MM |
| Profit(Loss)* | $-65.68MM | $-23.55MM | $126.04MM |
| Stockholders Equity | $311.74MM | $344.03MM | $476.72MM |
| Inventory | $21.56MM | $22.46MM | $64.43MM |
| Assets | $366.34MM | $441.19MM | $707.54MM |
| Operating Cash Flow | $-26.53MM | $73.48MM | $251.08MM |
| Capital expenditure | $7.25MM | $26.49MM | $52.75MM |
| Investing Cash Flow | $34.70MM | $-12.11MM | $-19.05MM |
| Financing Cash Flow | $-33.13MM | $-11.47MM | $-107.84MM |
| Earnings Per Share** | $-0.32 | $-0.11 | $0.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.